Wells Fargo & Company Ac Immune Sa Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Ac Immune Sa stock. As of the latest transaction made, Wells Fargo & Company holds 997,621 shares of ACIU stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

997,621

Previous 995,636 0.2%

Holding current value

$1.66 Million

Previous $2.69 Million 30.62%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$1.87 - $2.98 $3,711 - $5,915	1,985 Added 0.2%	997,621 $1.87 Million
Q4 2024 Feb 12, 2025	SELL	$2.67 - $3.75 $300,113 - $421,507	-112,402 Reduced 10.14%	995,636 $2.69 Million
Q3 2024 Nov 13, 2024	SELL	$2.99 - $4.2 $41,797 - $58,711	-13,979 Reduced 1.25%	1,108,038 $4.19 Million
Q2 2024 Aug 13, 2024	BUY	$2.29 - $4.87 $5,299 - $11,269	2,314 Added 0.21%	1,122,017 $4.48 Million
Q1 2024 May 10, 2024	SELL	$2.66 - $4.87 $77,108 - $141,171	-28,988 Reduced 2.52%	1,119,703 $3.31 Million
Q4 2023 Feb 09, 2024	BUY	$2.46 - $5.0 $6,408 - $13,025	2,605 Added 0.23%	1,148,691 $5.74 Million
Q3 2023 Nov 13, 2023	BUY	$2.77 - $3.38 $17,528 - $21,388	6,328 Added 0.56%	1,146,086 $3.27 Million
Q2 2023 Aug 15, 2023	BUY	$1.85 - $3.4 $301,413 - $553,948	162,926 Added 16.68%	1,139,758 $3.37 Million
Q1 2023 May 12, 2023	BUY	$2.13 - $2.49 $525,914 - $614,800	246,908 Added 33.83%	976,832 $2.29 Million
Q4 2022 Feb 13, 2023	BUY	$1.72 - $3.12 $134,789 - $244,501	78,366 Added 12.03%	729,924 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$2.4 - $3.64 $263,505 - $399,650	109,794 Added 20.27%	651,558 $2.06 Million
Q2 2022 Aug 12, 2022	BUY	$2.35 - $4.47 $118,458 - $225,323	50,408 Added 10.26%	541,764 $1.96 Million
Q1 2022 May 16, 2022	BUY	$3.5 - $5.16 $270,466 - $398,744	77,276 Added 18.66%	491,356 $1.97 Million
Q4 2021 Feb 14, 2022	BUY	$4.83 - $7.56 $298,397 - $467,056	61,780 Added 17.54%	414,080 $2.05 Million
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $106,615 - $143,414	17,196 Added 5.13%	352,300 $2.36 Million
Q2 2021 Aug 16, 2021	BUY	$6.04 - $8.37 $85,617 - $118,644	14,175 Added 4.42%	335,104 $2.66 Million
Q1 2021 May 13, 2021	SELL	$5.32 - $8.96 $13,433 - $22,624	-2,525 Reduced 0.78%	320,929 $2.44 Million
Q4 2020 Feb 09, 2021	BUY	$4.47 - $5.58 $516,325 - $644,540	115,509 Added 55.55%	323,454 $1.67 Million
Q3 2020 Nov 05, 2020	BUY	$4.78 - $9.06 $132,898 - $251,895	27,803 Added 15.43%	207,945 $1.02 Million
Q2 2020 Aug 13, 2020	SELL	$6.57 - $8.3 $193,144 - $244,003	-29,398 Reduced 14.03%	180,142 $1.21 Million
Q1 2020 May 14, 2020	BUY	$4.24 - $9.89 $888,449 - $2.07 Million	209,540 New	209,540 $1.45 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

27.4M

Call Options Held

4.8K

Put Options Held

22.2K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $138M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ac Immune Sa Transaction History